Skip to main content
. 2020 Oct 17;14:100397. doi: 10.1016/j.ebr.2020.100397

Table 3.

Lead time to treatment and treatment response.

Lead time N (%) responding to first line therapy Cumulative N (%) responding to second line therapy N (%) with resistant spasms at 3 months χ2 test for trend (resistant spasms at 3 months) N with missing information of treatment response
≤7 days 10/11 (91%) 11/11 (100%) 0/11 (0%) 2 = 10.0 (1 d.f.), p = 0.0015) 1
8-14 days 9/16 (56%) 15/16 (94%) 1/16 (6%) 0
15 days to 2 months 23/44 (52%) 30/44 (68%) 14/44 (32%) 2
> 2 months 19/38 (50%) 23/38 (61%) 15/38 (39%) 0